| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/08/2001 | WO2000053758A3 Compositions and methods for the treatment of immune related diseases |
| 02/08/2001 | WO2000053755A3 Compositions and methods for the treatment of tumor |
| 02/08/2001 | WO2000048617A3 Connective tissue softening |
| 02/08/2001 | WO2000030672A8 Collagen based biomaterials and methods of preparation and use |
| 02/08/2001 | WO2000024365A8 Treatment of skin with adenosine or adenosine analog |
| 02/08/2001 | WO2000011150A8 Cell surface immunomodulators |
| 02/08/2001 | DE19937219A1 Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Ionenaustauscherchromatographie A process for the purification of the blood clotting factor VII-activating protease, its pro-enzyme or a mixture of both proteins by ion-exchange chromatography |
| 02/08/2001 | DE19937218A1 Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie A process for the purification of the blood clotting factor VII-activating protease, its pro-enzyme or a mixture of both proteins by affinity chromatography |
| 02/08/2001 | DE19935303A1 Oligonukleotide zur Inhibierung der Expression von humanem eg5 Oligonucleotides for inhibiting the expression of human Eg5 |
| 02/08/2001 | DE19935302A1 Konjugate und Verfahren zu deren Herstellung sowie deren Verwendung zum Transport von Molekülen über biologische Membranen Conjugates and methods for their preparation and their use for transporting molecules across biological membranes |
| 02/08/2001 | CA2697207A1 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 02/08/2001 | CA2647796A1 Method of inhibiting osteoclast activity |
| 02/08/2001 | CA2391348A1 Enhanced delivery via serpin enzyme complex receptor |
| 02/08/2001 | CA2389719A1 Antifungic compositions and method for controlling fungi |
| 02/08/2001 | CA2388663A1 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 02/08/2001 | CA2381945A1 Mammalian adhesion protease peptides |
| 02/08/2001 | CA2381565A1 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 02/08/2001 | CA2381004A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 02/08/2001 | CA2380837A1 High affinity tgf.beta. nucleic acid ligands and inhibitors |
| 02/08/2001 | CA2380803A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380631A1 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 02/08/2001 | CA2380578A1 Ring opened cpis |
| 02/08/2001 | CA2380573A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 02/08/2001 | CA2380535A1 High affinity vascular endothelial growth factor (vegf) receptor nucleic acid ligands and inhibitors |
| 02/08/2001 | CA2380473A1 Tenascin-c nucleic acid ligands |
| 02/08/2001 | CA2380472A1 Gene specifically expressed in human fetal cardiac muscle |
| 02/08/2001 | CA2380428A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/08/2001 | CA2380379A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 02/08/2001 | CA2380354A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 02/08/2001 | CA2380111A1 Controlled release implantable devices |
| 02/08/2001 | CA2380009A1 Methods of inhibiting osteoclastogenesis |
| 02/08/2001 | CA2380007A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378929A1 Serine proteases |
| 02/08/2001 | CA2378432A1 Proteins and peptides |
| 02/08/2001 | CA2378331A1 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | CA2378182A1 Compositions and methods for the treatment of tumors |
| 02/08/2001 | CA2378140A1 Methods for transdifferentiation of body tissues |
| 02/08/2001 | CA2376245A1 Binding moieties for fibrin |
| 02/08/2001 | CA2374743A1 Human chaperone proteins |
| 02/07/2001 | EP1074842A1 Catalytic anti-factor VIII allo-antibodies |
| 02/07/2001 | EP1074634A1 Method for the diagnosis or the prognosis of Alzheimer disease therapeutical composition for preventing or treating Alzheimer disease |
| 02/07/2001 | EP1074627A2 25-hydroxyvitamin D3-1a-hydroxylase and DNA encoding the hydroxylase |
| 02/07/2001 | EP1074623A1 ABC transporter |
| 02/07/2001 | EP1074622A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF |
| 02/07/2001 | EP1074621A1 Human tsc403 gene and human ing1l gene |
| 02/07/2001 | EP1074620A1 Monomeric protein of the TGF-beta family |
| 02/07/2001 | EP1074619A2 Promoter for neuropeptide FF and use thereof for therapy and diagnostics |
| 02/07/2001 | EP1074618A2 Cadherin materials and methods |
| 02/07/2001 | EP1074616A1 Process for purification of the factor VII-activating protease, its proenzyme or a mixture of both proteins, by ion-exchange chromatography |
| 02/07/2001 | EP1074615A1 Methods for purification of Factor VII activating Protease, its proenzyme or a mixture of both forms, by affinity chromatography |
| 02/07/2001 | EP1074561A2 Analogues of lipopolysaccharide-binding protein (LBP)-derived peptides |
| 02/07/2001 | EP1074560A2 Crude extract from viscum album coloratum, and proteins and lectins isolated therefrom |
| 02/07/2001 | EP1074559A1 Peptide nucleic acids |
| 02/07/2001 | EP1074268A1 Preventives or remedies for inflammatory intestinal diseases containing as the active ingredient il-6 antagonists |
| 02/07/2001 | EP1074267A1 Induction of antigen-specific T cells by interferon |
| 02/07/2001 | EP1074265A1 Use of AMH and/or AMH agonists and/or AMH antagonists for long-term control of female fertility |
| 02/07/2001 | EP1074264A1 Neovascularization inhibitors |
| 02/07/2001 | EP1074263A2 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoylate saturated hydroxy-fatty acid |
| 02/07/2001 | EP1074248A1 Delivery system for biological material |
| 02/07/2001 | EP1073905A1 Methods of selecting internalizing antibodies |
| 02/07/2001 | EP1073759A1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof |
| 02/07/2001 | EP1073754A2 Mutant proteases having lower allergenic response in humans and methods for constructing, identifying and producing such proteases |
| 02/07/2001 | EP1073752A1 PROTEIN WITH THE AMINO ACID SEQUENCE OF DELTA 7 STEROL REDUCTASE,ISOLATED cDNA MOLECULE CODING FOR SAID PROTEIN, RECOMBINANT DNA VECTOR AND BIOLOGICALLY ACTIVECOMPOSITIONS CONTAINING SAID PROTEIN OR SAID cDNA MOLECULE |
| 02/07/2001 | EP1073751A2 Polypeptide with immunogenic properties and with a protein with modified biological functions |
| 02/07/2001 | EP1073750A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 02/07/2001 | EP1073746A2 Bacterial yjeq polypeptide family |
| 02/07/2001 | EP1073745A2 Immunization against and treatment for infection by h. pylori |
| 02/07/2001 | EP1073742A2 Human nucleic acid sequences of bladder tumour tissue |
| 02/07/2001 | EP1073741A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 02/07/2001 | EP1073740A1 Polynucleotides isolated from skin cells and methods for their use |
| 02/07/2001 | EP1073739A2 Cd40-interacting and traf-interacting proteins |
| 02/07/2001 | EP1073738A2 Human k+ ion channel and therapeutic applications thereof |
| 02/07/2001 | EP1073737A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/07/2001 | EP1073736A1 Delayed rectifier potassium channel subunit |
| 02/07/2001 | EP1073735A1 Host-encoded protein expressed on marek's disease virus (mdv)-infected cells and antibody thereto |
| 02/07/2001 | EP1073734A2 Tumor associated nucleic acids and uses therefor |
| 02/07/2001 | EP1073733A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY |
| 02/07/2001 | EP1073731A2 Nucleic acid enzyme for rna cleavage |
| 02/07/2001 | EP1073729A2 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 02/07/2001 | EP1073728A2 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 02/07/2001 | EP1073727A2 Human nucleic acid sequences from ovarian tumour tissue |
| 02/07/2001 | EP1073723A2 Ste20-related protein kinases |
| 02/07/2001 | EP1073720A2 Efficient ex vivo expansion of cd4+ and cd8+ t-cells from hiv infected subjects |
| 02/07/2001 | EP1073713A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae |
| 02/07/2001 | EP1073710A2 Non-stochastic generation of genetic vaccines and enzymes |
| 02/07/2001 | EP1073683A1 G-csf receptor agonist antibodies and screening method therefor |
| 02/07/2001 | EP1073682A1 Heparanase specific molecular probes and their use in research and medical applications |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073680A1 Protein mixtures to induce therapeutic angiogenesis |
| 02/07/2001 | EP1073679A1 Peptide fragments of murine epidermal growth factor as laminin receptor targets |
| 02/07/2001 | EP1073678A1 Peptide with endotoxin-neutralizing activity |
| 02/07/2001 | EP1073677A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 02/07/2001 | EP1073674A1 Thiol inhibitors of endothelin-converting enzyme |
| 02/07/2001 | EP1073672A1 Antipicornaviral compounds, their preparation and use |
| 02/07/2001 | EP1073671A1 Targeted gene delivery to cells by filamentous bacteriophage |
| 02/07/2001 | EP1073669A2 Gcp |
| 02/07/2001 | EP1073485A1 Fully recombinant tissue sealant compositions |
| 02/07/2001 | EP1073471A1 Method of treating endotoxemia |
| 02/07/2001 | EP1073465A1 T cell inhibitory receptor compositions and uses thereof |